• Facility page banner

ASC Facility


Facility Activities Product/Services Technology Application

Milipitas, CA

Design, develop, manufacture and distribute

Reference standards, iPSC, cell line, disease-specific isogenic models, cell models, animal models


Advance stem cell and gene-editing tools for use in biomedical research, drug discovery, bio-processing, bio-production and preclinical applications

CRO Information


Basic Research, Disease Discover, Drug Discover, In Vitro In Vivo

Preclinical Development, Bioanalysis, Bioanalytics

Customer Needs

  • Potential Utilization
  • Drug Safety
  • Chemical Characterization
  • Physical Characterization

GLP Services

  • Mouse toxicity studies
  • Gene editing assays in vitro and in vivo 


Not Regulated


FDA 21 CFR 58



IND Enabling – GLP

  • On-target and off-target analysis using
    • gRNA in-silico
    • ddPCR
    • NGS
  • gene editing validation in cells, including primary cells
  • gene editing validation in animal models
  • Efficacy
  • Validation
    • In-Silico
    • Guide sequence
    • Circle sequence
    • Rhan Sequence


IND Enabling – GLP

  • research grade AAV production
  • plasmid construction and production
  • research grade stem cell production and gene editing


Quality System for Good Laboratory Practices (GLP) focus on organizational process and conditions under which non-clinical health and environment safety studies are planned, performed, monitored, recorded, archived and reported.

Non-clinical lab studies that support or are intended to support application for research or marketing permits for the following products:

  • Human and animal drugs
  • Medical device for human use
  • Biological products

Document Control

  • QA Review SOP, Protocol, Study Report for GLP compliance
  • Written Protocol contains objective, methods, test article, test system, nature of study, date of study, current status, sponsor, study director
  • QA Inspection Records (Interval)
  • History File archive will be kept for 5 years
  • Archive will be audit by FDA
  • Facility Control
  • Lab Operation
  • Animal Care
  • Equipment Notebook, Calibration, Maintenance
  • SOP
  • Reagent
  • Storage

Test & Control Article

  • Characterization-
  • Identity, Strength, Purity, Stability, Uniformity
  • Handling-
  • Storage

Our Transgenic Animal Facility

Applied StemCell understands that our customers require reliable, genetically defined, transgenic animal models with specific health status and reports. We are committed to the highest quality standards in animal care and health and we utilize a state of the art animal facility in the San Francisco Bay Area, California. Our facility is designed, and expertly managed, for housing genetically modified mice and rats. All of our knock out, knock-in and transgenic animal models ship from this location. We are able to ship globally to any animal facility of your choice. Health monitoring records are available for review prior to shipping.

Housing, Accreditation and Staffing

Our animals are housed in a Specific Pathogen Free (SPF) facility with routine and comprehensive health monitoring. Please ask to see the list of pathogenic agents that we test for here. All animals are maintained in a combination of IVC and filtertop caging which are routinely cleaned, disinfected and sterilized. We house our animals in a facility with rigorous security and access to authorized personnel only. We use irradiated food, LabDiet 5015 for mice and LabDiet 5012 for rats, and we provide enrichment materials in every cage.

Our housing facility is under contract with LifeSource Biomedical Services, LLC  at the NASA Ames Research Center. All work is under the independent oversight of the NASA ARC Institutional Animal Care and Use Committee, as mandated by the Animal Welfare Act of 1966 and the following amendments (7 USC, 2131 – 2159). The environmental controls at NASA Ames conform to engineering standards set forth in the 8th Edition of the Guide for Care and Us of Laboratory Animals http://dels.nas.edu/Report/Guide-Care/12910

We are committed to animal welfare and to consistent, genetically correct and reliable research animal models. Our facility is accredited by AAALAC and the PHS and OLAW assurances of NASA Ames. AAALAC accreditation assures that all work conforms to US regulation and the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, Council of Europe.

Our transgenic animal facility is staffed by quality professional technicians with extensive relevant industry experience and overseen by a laboratory animal veterinarian. The physical health of our animals is monitored every day. Any animal that appears injured or ill is referred to our veterinarian for treatment, untreatable animals are euthanized.

Please contact us if you have any questions about our transgenic animal facility, health monitoring or shipment procedures.

ISO 9001, ISO 13485

Applied StemCell, Inc., a global provider of gene editing and stem cell-based services, as well as, a leader in molecular and cellular reference standard products for clinical diagnostics markets, is proud to receive certifications for two International Organization for Standardization (ISO) Quality Management Systems (QMS) on October 20, 2017, the ISO9001:2015 and 13485:2016.

The ISO certification entails extensive documentation and creation of standard operating procedures (SOP) to ensures quality services and products, customer satisfaction, continued improvement in processes, quality and workflow, and conformity to customer and regulatory requirements. The certificate approves Applied StemCell, Inc., located in Milpitas, California (USA), providing gene-editing, stem cell, and reference standard products and services for life science research, preclinical, and clinical diagnostic global markets.  In addition, we have also been awarded the ISO 13485 certification for consistently meeting customer and regulatory requirements for products and services related to medical devices, and specifically to our reference standard products.


Regulatory Compliance


ISO 13485:2016

Quality Management System to meet customer and regulatory requirement on the design, development, production, storage, manufacture, distribution, installation and servicing of medical device products


ISO 9001:2015

Quality Management System to improve customer satisfaction, increase process efficiency, identify risk, continuous improvement, evidence-based decision making